Chief Human Resources Officer

President

Revolution Medicines’ RAS(ON) Multi-Selective Inhibitor Daraxonrasib Granted U.S. FDA Orphan Drug Designation in Pancreatic Cancer

Revolution Medicines stock rises after FDA grants Orphan Drug Designation

Revolution Medicines announces U.S. FDA granted ODD to daraxonrasib

Revolution Medicines reports elironrasib data for lung cancer patients

Associate Director, Talent and Learning Platforms

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies. The role involves owning and expanding Workday Learning and Talent Management while collaborating with HR and cross-functional teams to enhance employee experiences and operational excellence.

VP, Talent Acquisition

Executive Director, Head of Talent Acquisition

Vice President, Total Rewards & People Operations and HRBP, Development

Senior Director, Commercial Training, Learning & Development

Senior Employee Engagement Specialist

Sign up with Google

Sign in with Google